Back to Journals » Vascular Health and Risk Management » Volume 12

Does the treatment of type 2 diabetes mellitus with the DPP-4 inhibitor vildagliptin reduce HbA1c to a greater extent in Japanese patients than in Caucasian patients?

Total article views   Abstract views HTML views PDF downloads Totals
6,485 Dovepress* 4,964 945+ 1,885 5,909
PubMed Central* 0 576 256 576
Totals 4,964 1,521 2,141 6,485
*Since 21 January 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar